Female Health Financial Statements
Female Health Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | September |
© 2009 Morningstar, Inc. Financial Data provided by
Female Health Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 25.6 | 19.3 | 14.8 |
| Gross Profit ($ mil.) | 10.7 | 7.2 | 5.5 |
| Operating Income ($ mil.) | -- | 0.9 | -- |
| Total Net Income ($ mil.) | 5.0 | 1.5 | 0.1 |
| Diluted EPS (Net Income) | 0.18 | 0.06 | 0.01 |
Female Health Stock Quote & Chart
•
NASDAQ •
--
•
•
%
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Female Health Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 5.01 | 2.06 | 7.00 |
| Price/Earnings Ratio | 20.79 | 20.41 | 25.45 |
| Price/Book Ratio | 12.72 | 3.72 | 6.74 |
| Price/Cash Flow Ratio | 17.99 | 13.59 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Female Health Financial Ratios
Female Health Competitive Intelligence
| BB MEDTECH | G & D Enterprises | Johnson & Johnson | |
|---|---|---|---|
| Annual Sales ($ mil.) | 69.9 | 2.7 | 63,747.0 |
| Employees | 0 | 11 | 118,700 |
| Market Cap ($ mil.) | 1,452.9 | -- | 165,490.8 |
Competitive Landscape
